Changeflow GovPing Pharma & Drug Safety Improved Method for LSD Production and Novel De...
Routine Notice Added Final

Improved Method for LSD Production and Novel Derivatives

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4178956A2 for MiHKAL GmbH on April 1, 2026, covering an improved method for producing lysergic acid diethylamide (LSD) and novel derivatives thereof. The patent application, filed under IPC classification C07D (heterocyclic compounds), designates 31 European contracting states including Germany, France, and the United Kingdom.

What changed

EPO published patent application EP4178956A2 for MiHKAL GmbH's improved method of producing LSD (lysergic acid diethylamide) and novel derivatives. The application classifies under C07D 457/06 and related heterocyclic compound categories, with therapeutic classifications in A61P 25/22 (psychoanaleptics) and A61K 31/48.

Pharmaceutical companies and chemical manufacturers operating in the EU should monitor this patent's progression through grant. If granted, MiHKAL GmbH gains exclusive rights to the production method across 31 designated European states, potentially affecting research and development activities involving lysergic acid derivatives.

What to do next

  1. Monitor patent register for grant confirmation
  2. Review licensing implications if operating in pharmaceutical manufacturing

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

IMPROVED METHOD FOR THE PRODUCTION OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND NOVEL DERIVATIVES THEREOF

Publication EP4178956A2 Kind: A2 Apr 01, 2026

Applicants

MiHKAL GmbH

Inventors

GRILL, Matthias

IPC Classifications

C07D 457/06 20060101AFI20230207BHEP C07D 457/08 20060101ALI20230207BHEP C07D 519/00 20060101ALI20230207BHEP A61P 25/22 20060101ALI20230207BHEP A61K 31/48 20060101ALI20230207BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

Method for Production of Lysergic Acid Diethylamide (LSD)

Get daily alerts for ChangeBridge: EPO Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
EPO
Published
April 1st, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4178956A2

Who this affects

Applies to
Pharmaceutical companies Legal professionals Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent granting IP licensing Pharmaceutical manufacturing
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.